Monkeypox among Men Who Have Sex with Men in Africa: the Need for Testing and Vaccination Beyond Stigma

Emery Manirambona,Deborah Oluwaseun Shomuyiwa,Shuaibu Saidu Musa,Don Eliseo Lucero‐Prisno
DOI: https://doi.org/10.1002/jmv.28121
IF: 20.693
2022-01-01
Journal of Medical Virology
Abstract:The Monkeypox virus (MPX) outbreak has been classified at the highest-level alert because of an upsurge in cases worldwide. It has been prominent in European countries and the United Kingdom, where it has significantly impacted men who have sex with men (MSM). There have been sporadic reports of MPX cases and mortality in Africa, which has had numerous negative effects. However, even among newly confirmed cases, no reports of MSM have been made in Africa. This lack of MPX cases among African MSM is probably due to insufficient testing resources. Most importantly, the stigma that MSM face in African society prevents them from seeking timely medical attention and leaves them feeling neglected or uncared for. Although an effective preventive strategy to reduce MPX cases among MSM is to reduce the number of sexual partners and avoid contact with suspected people, it is crucial to defend the marginalised MSM community in Africa via MSM testing and vaccination. It would be crucial to conduct MPX testing among the African MSM community to confirm the incidence rate and inform policymakers to implement the necessary precautions. In order to protect the community and promote health equity, vaccination of MSM should be a top priority. This article is protected by copyright. All rights reserved.
What problem does this paper attempt to address?